These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29748876)

  • 1. ypTNM staging after neoadjuvant chemotherapy in the Chinese gastric cancer population: an evaluation on the prognostic value of the AJCC eighth edition cancer staging system.
    Li Z; Wang Y; Shan F; Ying X; Wu Z; Xue K; Miao R; Zhang Y; Ji J
    Gastric Cancer; 2018 Nov; 21(6):977-987. PubMed ID: 29748876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different prognostic implication of ypTNM stage and pTNM stage for gastric cancer: a propensity score-matched analysis.
    Li Z; Wang Y; Ying X; Shan F; Wu Z; Zhang L; Li S; Jia Y; Ren H; Ji J
    BMC Cancer; 2019 Jan; 19(1):80. PubMed ID: 30651085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a staging system for gastric adenocarcinoma after neoadjuvant chemotherapy and gastrectomy with D2 lymphadenectomy.
    Lin JX; Yoon C; Desiderio J; Yi BC; Li P; Zheng CH; Parisi A; Huang CM; Strong VE; Yoon SS
    Br J Surg; 2019 Aug; 106(9):1187-1196. PubMed ID: 31197829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic differences in 8th edition TNM staging of esophagogastric adenocarcinoma after neoadjuvant treatment.
    Sisic L; Blank S; Nienhüser H; Dorr S; Haag GM; Jäger D; Bruckner T; Müller-Stich BP; Ott K; Büchler MW; Ulrich A; Schmidt T
    Eur J Surg Oncol; 2018 Oct; 44(10):1646-1656. PubMed ID: 30082176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified ypTNM Staging Classification for Gastric Cancer after Neoadjuvant Therapy: A Multi-Institutional Study.
    Zhong Q; Chen QY; Parisi A; Ma YB; Lin GT; Desiderio J; Yan S; Xie JW; Wang JB; Hou JF; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Liu ZY; Que SJ; Li P; Zheng CH; Huang CM
    Oncologist; 2021 Jan; 26(1):e99-e110. PubMed ID: 32864840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Tumor Staging System Incorporating Tumor Regression Grade (TRG) With Lymph Node Status (ypN-Category) Results in Better Prognostication Than ypTNM Stage Groups After Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma.
    Wong IYH; Chung JCY; Zhang RQ; Gao X; Lam KO; Kwong DLW; Chao YK; Law SYK
    Ann Surg; 2022 Nov; 276(5):784-791. PubMed ID: 35876374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of tumor regression grade (TRG) after oncological gastrectomy for gastric cancer.
    Abboretti F; Mantziari S; Didisheim L; Schäfer M; Teixeira Farinha H
    Langenbecks Arch Surg; 2024 Jun; 409(1):199. PubMed ID: 38935163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Postoperative complications and their influence on the prognosis factors in gastric cancer patients receiving neoadjuvant treatment].
    Wang TB; Mao QK; Zhang XJ; Zhou H; Guo CG; Chen YT; Zhao DB
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):160-166. PubMed ID: 33508922
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluating the eighth edition TNM staging system for esophageal cancer among patients receiving neoadjuvant therapy: A SEER study.
    Yuan Y; Ma G; Hu X; Huang Q
    Cancer Med; 2020 Jul; 9(13):4648-4655. PubMed ID: 32391623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ypTNM staging is a potentially useful prognostic stratification tool in patients with advanced gastric cancer after preoperative chemotherapy.
    Otsuka R; Hayano K; Hayashi H; Uesato M; Murakami K; Toyozumi T; Matsumoto Y; Kurata Y; Nakano A; Matsubara H
    Langenbecks Arch Surg; 2023 Mar; 408(1):133. PubMed ID: 37000278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the ypTNM-stage adequately predict long-term survival rates in gastric cancer patients receiving neoadjuvant chemotherapy followed by radical resection?
    Sandø AD; Grønbech JE; Bringeland EA
    Acta Oncol; 2023 Dec; 62(12):1846-1853. PubMed ID: 37903117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proposed modification of the eighth edition of the AJCC-ypTNM staging system of esophageal squamous cell cancer treated with neoadjuvant chemotherapy: Unification of the AJCC staging system and the Japanese classification.
    Oshikiri T; Goto H; Kato T; Sawada R; Harada H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Fujino Y; Tominaga M; Kakeji Y
    Eur J Surg Oncol; 2022 Aug; 48(8):1760-1767. PubMed ID: 35094909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy.
    Tong Y; Zhao Y; Shan Z; Zhang J
    BMC Cancer; 2021 Jan; 21(1):4. PubMed ID: 33402124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic value and initial exploratory research on TNM staging method of tumor deposits in stage III colon cancer].
    Qin Q; Yang L; Zhou AP; Wang JW; Zhong DS
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1152-1158. PubMed ID: 31874531
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparison of the superiority of different TNM staging systems in Siewert III adenocarcinoma of esophagogastric junction].
    Lu Y; Xi H; Xie T; Qiu Z; Wang X; Wei B; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):143-148. PubMed ID: 30799536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of neoadjuvant downstaging in gastric adenocarcinoma.
    Prasad P; Sivaharan A; Navidi M; Fergie BH; Griffin SM; Phillips AW
    Surgery; 2022 Aug; 172(2):593-601. PubMed ID: 35400501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of clinicopathological characteristics and prognosis on 42 patients with primary gastric adenosquamous cell carcinoma].
    Li B; Sun L; Wang X; Deng J; Ding X; Wang X; Ke B; Zhang L; Zhang R; Liang H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):207-212. PubMed ID: 28226357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
    Zhu Y; Sun Y; Hu S; Jiang Y; Yue J; Xue X; Yang L; Xue L
    BMC Gastroenterol; 2017 Mar; 17(1):41. PubMed ID: 28292272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological evaluation of neoadjuvant chemotherapy in advanced gastric cancer.
    Hu SB; Liu CH; Wang X; Dong YW; Zhao L; Liu HF; Cao Y; Zhong DR; Liu W; Li YL; Gao WS; Bai CM; Shang ZH; Li XY
    World J Surg Oncol; 2019 Jan; 17(1):3. PubMed ID: 30606195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ypT category does not impact overall survival in node negative gastric cancer.
    Ikoma N; Hofstetter WL; Estrella JS; Das P; Minsky BD; Fournier KF; Mansfield PF; Ajani JA; Badgwell BD
    J Surg Oncol; 2018 Jun; 117(8):1721-1728. PubMed ID: 29949666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.